 Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
| Descriptor ID |
D009169
|
| MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 1999 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 4 | 1 | 5 | | 2002 | 2 | 1 | 3 | | 2003 | 9 | 0 | 9 | | 2004 | 9 | 2 | 11 | | 2005 | 6 | 3 | 9 | | 2006 | 7 | 4 | 11 | | 2007 | 6 | 3 | 9 | | 2008 | 4 | 1 | 5 | | 2009 | 7 | 5 | 12 | | 2010 | 4 | 2 | 6 | | 2011 | 7 | 3 | 10 | | 2012 | 10 | 6 | 16 | | 2013 | 4 | 3 | 7 | | 2014 | 9 | 2 | 11 | | 2015 | 11 | 1 | 12 | | 2016 | 14 | 4 | 18 | | 2017 | 12 | 3 | 15 | | 2018 | 3 | 2 | 5 | | 2019 | 11 | 1 | 12 | | 2020 | 5 | 4 | 9 | | 2021 | 10 | 1 | 11 | | 2022 | 4 | 0 | 4 | | 2023 | 13 | 0 | 13 | | 2024 | 8 | 1 | 9 | | 2025 | 4 | 3 | 7 | | 2026 | 7 | 1 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
Cummings JE, Woolhiser LK, Guglielmi V, Romano A, Pauly S, Zimmerman M, Kaya F, Walter ND, Robertson GT, Slayden RA. Pretomanid vs delamanid in a bedaquiline-linezolid regimen: efficacy in a high-burden tuberculosis mouse model. Antimicrob Agents Chemother. 2026 Jun 03; 70(6):e0195325.
-
Hendrix J, Al Mubarak R, Reichlen MJ, Tabor ST, Bateman A, Massoudi LM, Rossmassler K, Kaya F, Zimmerman MD, Nielsen H, Wynn EA, Voskuil MI, Robertson GT, Moore CM, Walter ND. Physiologic recovery of Mycobacterium tuberculosis from drug injury: A molecular study of post antibiotic effect in vitro and in vivo. PLoS Pathog. 2026 Apr; 22(4):e1014131.
-
Sharma M, Afghan S, Singh A, Alam I, Agarwal M, Shahid M, Atif SM, Khan S, Malik SS, Yenuganti VR, Ansari MA. Mycobacterium tuberculosis antigen-containing exosomes reinforce BCG vaccine efficacy by augmenting long-term protection and memory response against experimental tuberculosis in BALB-C mice. Front Immunol. 2026; 17:1742207.
-
Yengkhom D, Montepiedra G, Masheto G, Wabwire D, Stranix-Chibanda L, Matubu A, Violari A, Theron G, Gupta A, Weinberg A. Tuberculosis preventive therapy in postpartum women with HIV modifies M. tuberculosis-specific and nonspecific immune responses. Front Immunol. 2026; 17:1722621.
-
Riedel C, Rahkola J, Reichlen M, Ries H, Ericksen SS, Voskuil M, Gitter A, Wlodarchak N. Identification and characterization of inhibitors of the tuberculosis phosphatase PstP. J Biol Chem. 2026 Apr; 302(4):111316.
-
Meena S, Fatima F, Qais FA, Ramachandran S. Computational screening of natural plant and marine compounds as potential inhibitors of Mycobacterium tuberculosis dihydrodipicolinate synthase. Comput Biol Chem. 2026 06; 122:108936.
-
Ye N, Del Rio Flores A, Zhang W, Drennan CL. A highly dynamic mononuclear non-heme iron enzyme for the two-step isonitrile biosynthesis. Nat Commun. 2026 Jan 26; 17(1).
-
Sordello S, Brock L, Tagliavini A, Federico D, Boulenc X, Pergher M, Huc Claustre E, Metcalf D, Walter ND, Robertson GT, Clary J, Berg A, Mdluli K, Hermann D, Flood D, Upton AM. A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model. Antimicrob Agents Chemother. 2026 Feb 04; 70(2):e0110925.
-
Goletti D, Banaei N, Batra R, Berger AE, Blazevic A, Botelho-Nevers E, Breen R, Bruiners N, Cambau E, Carbonnelle E, Daley CL, Descotes-Genon C, Gennaro FD, Doucet-Populaire F, Esmail A, Guzman JDE, Fontana L, Gennaro ML, Handler D, Torres RMH, Hoft D, Ismail N, Isnard M, Kenny J, Lardizabal A, Lesage FX, Lopes A, Vidal WLL, Contreras RM, Manivet P, Marotte H, Méchaï F, Medjahed-Artebasse A, Meldau R, Mérieux Y, Morel J, Mougari F, Oelofse S, Palmieri F, Perrot JL, Petruccioli E, Pride DT, Tuaillon E, Upton C, Vanker N, Dheda K. Accuracy of VIDAS? TB-IGRA in TB patients and individuals with different thresholds of exposure. Int J Infect Dis. 2026 Mar; 164:108318.
-
Puffal J, Sparks IL, Brenner JR, Li X, Leszyk JD, Hayashi JM, Shaffer SA, Morita YS. Compartmentalized cell envelope biosynthesis in Mycobacterium tuberculosis. mBio. 2026 Jan 14; 17(1):e0268025.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|